Core Viewpoint - Hydreight Technologies Inc. successfully closed a "bought deal" private placement, raising a total of $15,005,250 through the issuance of 3,705,000 units at a price of $4.05 per unit, indicating strong investor confidence in the company's growth potential and business model [1][2][3]. Financing Details - The offering was oversubscribed shortly after its announcement, demonstrating strong conviction in Hydreight's execution and business model durability [2]. - The offering included an option for underwriters to increase the number of units sold by up to 1,235,000, which was fully exercised, bringing the total units issued to 3,705,000 [3]. - Each unit consists of one common share and one-half of a common share purchase warrant, with the warrants allowing the purchase of additional shares at $5.27 for 24 months [4]. Use of Proceeds - The net proceeds from the offering will be utilized to support sales growth, expand pharmacy production lines, and for general corporate purposes [6][7]. - The company aims to accelerate customer growth, enhance technology offerings, increase production capacity, and strengthen infrastructure to meet growing demand [3]. Company Overview - Hydreight Technologies Inc. is developing a large mobile clinic network across the U.S., with a platform that integrates over 2,500 nurses and 100 doctors, facilitating healthcare services directly to patients [10]. - The platform includes tools for accounting, documentation, sales, inventory, booking, and patient data management, empowering healthcare professionals to deliver services independently [10].

Core Insights - Hydreight Technologies Inc. has exceeded its operational target for 2025 by surpassing 1.3 million product orders placed ahead of year-end, reflecting strong platform adoption and partner demand [4][10][11] - The company has expanded its ecosystem to approximately 2,500 licenses, significantly exceeding its target of 1,000 for 2025, although many licenses are still in onboarding stages [7][10] - The focus remains on long-term value creation and disciplined execution as the company prepares for increased platform activity in 2026 [9][10][15] Operational Highlights - VSDHOne, the enterprise-focused vertical, began commercial activity in late June 2025 and has been progressively scaled [3] - The company achieved over 1.3 million product orders placed, surpassing its 2025 operational target, driven primarily by an initial base of approximately 400 fully onboarded licenses [4][10] - Hydreight continues to use product orders placed as its primary operational metric, reflecting real-time platform activity and demand [5][23] License and Platform Expansion - The company supports around 2,500 licenses, with the majority still in onboarding or early activation stages, which are not yet contributing significantly to order volume [7][10] - Management anticipates that utilization will scale progressively as onboarding is completed, positioning the company for increased activity in 2026 [7][15] Average Order Value and Strategic Focus - Average order value (AOV) reflects the early-stage scaling of newer offerings, with a focus on balancing order volume and product mix for long-term value creation [9][10] - The company is committed to building a durable and scalable business, with expectations for platform metrics to evolve as newer verticals mature [10] 2026 Guidance and Future Outlook - Hydreight plans to provide formal 2026 guidance early in the new year, following a review of several strategic initiatives, including enterprise partnerships and M&A opportunities [12][14] - The company is evaluating late-stage opportunities for enterprise customers, which will be incorporated into future guidance for a more accurate business outlook [13][14] Recognition and Growth - Hydreight was ranked as the 56th fastest-growing company in North America on the 2024 Deloitte Technology Fast 500™ and recognized as a top 50 TSX Venture Exchange company [16] - The company is expanding high-volume platform partners and increasing utilization across multiple healthcare categories, while also strengthening compliance and governance [16]

Core Viewpoint - Hydreight Technologies Inc. has successfully closed a private placement of unsecured convertible debentures, raising gross proceeds of C$11,500,000 to support its growth strategy and operational efficiency [1][4]. Group 1: Offering Details - The company issued a total of 11,500 convertible debentures at an issue price of C$1,000 each, including 1,500 debentures sold under the agent's over-allotment option [1]. - The debentures are unsecured, maturing on September 4, 2028, with an annual interest rate of 9.0%, payable semi-annually starting December 31, 2025 [2]. - Holders of the debentures can convert them into common shares at a conversion price of C$4.06 per share [2]. Group 2: Forced Conversion Right - The company has the option to force the conversion of the debentures if the volume-weighted average trading price of its common shares exceeds C$5.08 for 20 consecutive trading days [3]. - A notice will be provided to debenture holders if the forced conversion right is exercised, specifying the conversion date, which will be at least 30 days after the notice [3]. Group 3: Financial and Operational Insights - The CEO highlighted that the company has reached profitability as reflected in its Q2 financials and emphasized the importance of this funding for accelerating growth [4]. - The net proceeds from the offering will be utilized for general corporate and working capital purposes [5]. Group 4: Company Overview - Hydreight Technologies Inc. is developing a large mobile clinic network in the U.S., with a platform that connects over 2,500 nurses and 100 doctors across all 50 states [8]. - The platform includes integrated tools for healthcare professionals to provide services directly to patients, enhancing convenience and compliance [8].

Core Viewpoint - Hydreight Technologies Inc. has announced a private placement offering of up to C$10,000,000 in unsecured convertible debentures to support its digital healthcare solutions business [1][6] Group 1: Offering Details - The company has granted Canaccord Genuity Corp. an option to increase the offering size by up to C$1,500,000 [2] - The debentures will mature 36 months from issuance and are convertible into common shares at a price of C$4.06 per share [3] - The offering is expected to close around September 4, 2025, pending regulatory approvals [6] Group 2: Financial Terms - The debentures will bear a fixed interest rate of 9.0% per annum, payable semi-annually [5] - The company will pay a cash commission of 6.0% to the lead agent and issue compensation warrants equal to 6.0% of the number of shares issuable upon conversion [7] Group 3: Company Overview - Hydreight Technologies Inc. is building a large mobile clinic network in the U.S., with over 2,500 nurses and 100 doctors across 50 states [10] - The company's platform includes integrated tools for healthcare professionals to provide services directly to patients [10]